Chahinda Ghossein-Doha

Chahinda Ghossein-Doha

Auto-generated profile, based on publicly available information

Chahinda Ghossein-Doha

Department of Cardiology, Maastricht University Medical Center+, Maastricht, The Netherlands

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
CGC. Ghossein‐Doha
C. Ghossein‐Doha
JNJ. van Neer
J. van Neer
BWB. Wissink
B. Wissink
NBN. M. Breetveld
N. M. Breetveld
LWL. J. de Windt
L. J. de Windt
MSM. E. A. Spaanderman
M. E. A. Spaanderman
Objectives: Pre‐eclampsia (PE) is associated with both postpartum structural asymptomatic heart disease (i.e. heart failure Stage B (HF‐B)) and conventional cardiovascular (CV) risk factors. We aimed to evaluate the extent to which PE, adjusted for conventional CV risk factors, is associated independently with asymptomatic cardiac abnormalities postpartum.Methods: In this cross‐sectional cohort study, 107 formerly pre‐eclamptic women and 41 women with uneventful previous pregnancy (controls) were invited for CV risk assessment 4–10 years postpartum. This included cardiac ultrasound, blood pressure (BP) measurement and evaluation of metabolic syndrome determinants. Asymptomatic structural and functional cardiac abnormalities were classified as HF‐B, according to the American Heart Association guidelines. Prehypertension was defined as systolic BP of 120–139 mmHg and/or diastolic BP of 80–89 mmHg. Univariate and multivariate regression analyses were performed to calculate associations of PE and conventional risk factors with HF‐B.Results: The prevalence of asymptomatic HF‐B was approximately 3.5‐fold higher in the PE group compared with controls (25% vs 7%, P < 0.01); 67% of this group had concentric remodeling and 22% had mildly impaired ejection fraction. After adjustment for postpartum interval, hypertension and high‐density lipoprotein, PE was significantly associated with HF‐B (adjusted odds ratio, 4.4 (95% CI, 1.0–19.1)). Moreover, in the formerly pre‐eclamptic group, prehypertension was associated significantly with HF‐B (odds ratio, 4.3 (95% CI, 1.4–12.7)), while metabolic syndrome determinants were not.Conclusion: PE is associated with a four‐fold increased female‐specific risk of asymptomatic cardiac abnormalities. Prehypertension apparently increases this risk significantly, while metabolic syndrome determinants do not. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

1 August 2013 in Hypertension
Verified
Journal Article
Closed access
PDF file
CGChahinda Ghossein-Doha
Chahinda Ghossein-Doha
LPLouis Peeters
Louis Peeters
SHSanne van Heijster
Sanne van Heijster
SKSander van Kuijk
Sander van Kuijk
JSJulia Spaan
Julia Spaan
MSMarc Spaanderman
Marc Spaanderman
Preeclampsia is associated with a 4-fold higher risk for developing remote chronic hypertension. Preeclampsia is accompanied by left ventricular hypertrophy and decreased diastolic function, which may or may not resolve postpartum. We tested the hypothesis that increased measures of cardiac geometry and decreased cardiac function persisting for ≥6 months postpartum in normotensive women with a history of preeclampsia precede the development of later chronic hypertension. Formerly preeclamptic women (n=652) underwent echocardiography at 9 months (range, 6–19) postpartum. We excluded women with preexisting hypertension (n=42), hypertension at the postpartum screening (n=133), and those that did not return any checklist (n=128). Eventually, 349 women were included. Remote health was evaluated by a biennially checklist. We used Cox regression for analysis. Twenty-seven (8%) normotensive women had developed chronic hypertension during a medium follow-up period of 6 years. At screening they differed from their counterparts who remained normotensive by hazard ratio for left ventricular mass index (1.11; 95% confidence interval [CI], 1.03–1.18), diastolic blood pressure (1.13; 95% CI, 1.06–1.20), systolic blood pressure (1.07; 95% CI, 1.02–1.11), mean arterial pressure (1.11; 95% CI, 1.05–1.18), heart rate (1.05; 95% CI, 1.01–1.10), and E/A ratio (0.22; 95% CI, 0.06–0.85). Backward stepwise analysis showed independent hazard ratio for left ventricular mass index and diastolic blood pressure 1.08 (95% CI, 1.01–1.16) and 1.13 (95% CI, 1.06–1.21), respectively. In conclusion, the development of later chronic hypertension in initially normotensive formerly preeclamptic women is preceded by increased left ventricular mass index and diastolic blood pressure at postpartum screening.

1 December 2020 in eClinicalMedicine
Verified
Journal Article
Open access
VSVeronique M.M.M. Schiffer
Veronique M.M.M. Schiffer
EJEmma B.N.J. Janssen
Emma B.N.J. Janssen
BBBas C.T. van Bussel
Bas C.T. van Bussel
LJLaura L.M. Jorissen
Laura L.M. Jorissen
JTJeanette Tas
Jeanette Tas
CGChahinda Ghossein-Doha
Chahinda Ghossein-Doha
Many studies investigate the role of pharmacological treatments on disease course in Corona Virus Disease 2019 (COVID-19). Sex disparities in genetics, immunological responses, and hormonal mechanisms may underlie the substantially higher fatality rates reported in male COVID-19 patients. To optimise care for COVID-19 patients, prophylactic and therapeutic studies should include sex-specific design and analyses. Therefore, in this scoping review, we investigated whether studies on pharmacological treatment in COVID-19 were performed based on a priori sex-specific design or post-hoc sex-specific analyses. We systematically searched PubMed, EMBASE, UpToDate, clinical trial.org, and MedRxiv for studies on pharmacological treatment for COVID-19 until June 6th, 2020. We included case series, randomized controlled trials, and observational studies in humans (≥18 years) investigating antiviral, antimalarial, and immune system modulating drugs. Data were collected on 1) the proportion of included females, 2) whether sex stratification was performed (a priori by design or post-hoc), and 3) whether effect modification by sex was investigated. 30 studies were eligible for inclusion, investigating remdesivir (n = 2), lopinavir/ritonavir (n = 5), favipiravir (n = 1), umifenovir (n = 1), hydroxychloroquine/chloroquine (n = 8), convalescent plasma (n = 6), interleukin-6 (IL-6) pathway inhibitors (n = 5), interleukin-1 (IL-1) pathway inhibitors (n = 1) and corticosteroids (n = 3). Only one study stratified its data based on sex in a post-hoc analysis, whereas none did a priori by design. None of the studies investigated effect modification by sex. A quarter of the studies included twice as many males as females. Analyses assessing potential interference of sex with (side-)effects of pharmacological therapy for COVID-19 are rarely reported. Considering sex differences in case-fatality rates and genetic, immunological, and hormonal mechanisms, studies should include sex-specific analyses in their design to optimise COVID-19 care. None

23 September 2015 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
CGC. Ghossein‐Doha
C. Ghossein‐Doha
MSM. E. A. Spaanderman
M. E. A. Spaanderman
RDR. Al Doulah
R. Al Doulah
SKS. M. Van Kuijk
S. M. Van Kuijk
LPL. L. H. Peeters
L. L. H. Peeters
Objectives: Left‐ventricular remodeling in women with pre‐eclampsia (PE) is concentric rather than eccentric, and tends to persist postpartum, particularly after early‐onsetPE. This study was designed to determine whether prepregnancy cardiac geometry and function along with cardiac adaptation to the subsequent pregnancy in former early‐onsetPEpatients differs between those who do and those who do not develop recurrentPElater on in their second pregnancy.Methods: In 51 women with a history of early‐onsetPE, we performed serial cardiac ultrasound examinations and recorded automated measurements of blood pressure/heart rate before pregnancy and again at three consecutive times in the first half of their subsequent pregnancy. From the hospital records, we retrieved information on pregnancy outcome. We compared intergroup differences in cardiac indices using independent samplest‐test, and intergroup differences in prepregnant cardiac ultrasound indices and subsequent pregnancy‐induced cardiac adaptive response using repeated‐measuresANOVA.Results: PErecurred in 14/51 (27%) women. Preconception, the recurrent‐PEgroup differed from the non‐recurrent‐PEgroup by having a lower left‐ventricular mass (LVM) index (28vs32 g/m2.7,P < 0.05) and stroke volume (68vs77 mL,P < 0.05), and a higher resting heart rate (71vs64 bpm,P < 0.05). Despite these prepregnancy differences, the pregnancy‐induced pattern of cardiac adaptive response was comparable in the two subgroups. After excluding hypertensive women, prepregnancy values for theLVMindex remained significantly lower in the recurrent‐PEgroup.Conclusions: Women with recurrentPEdiffered from the non‐recurrent‐PEgroup by having a lowerLVMindex and stroke volume, and a higher heart rate, but they responded to their subsequent pregnancy with a similar pattern of cardiac adaptation. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.

1 July 2014 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
CGChahinda Ghossein-Doha
Chahinda Ghossein-Doha
MSMarc Spaanderman
Marc Spaanderman
SKSander M. J. van Kuijk
Sander M. J. van Kuijk
AKAbraham A. Kroon
Abraham A. Kroon
Tammo DelhaasTammo Delhaas
Tammo Delhaas
LPLouis Peeters
Louis Peeters

1 July 2019 in Pregnancy Hypertension
Verified
Journal Article
Closed access
EMEva Mulder
Eva Mulder
SBShumalla Basit
Shumalla Basit
JOJolien Oben
Jolien Oben
SKSander van Kuijk
Sander van Kuijk
CGChahinda Ghossein-Doha
Chahinda Ghossein-Doha
MSMarc Spaanderman
Marc Spaanderman